NCT02664909View on ClinicalTrials.gov

Topical (Intra-Articular) Tranexamic Acid and Transfusion Rates Following Hip Hemiarthroplasty

PHASE4CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

January 1, 2016

Primary Completion Date

June 30, 2019

Study Completion Date

June 30, 2019

Conditions
Femoral Neck Fractures
Interventions
DRUG

Tranexamic Acid

DRUG

Placebo (saline)

Trial Locations (2)

06030

University of Connecticut Health Center, Farmington

06105

Saint Francis Hospital and Medical Center, Hartford

All Listed Sponsors
collaborator

Orthopedic Research and Education Foundation

OTHER

lead

UConn Health

OTHER

NCT02664909 - Topical (Intra-Articular) Tranexamic Acid and Transfusion Rates Following Hip Hemiarthroplasty | Biotech Hunter | Biotech Hunter